Christopher Mueller
0000-0001-5979-6195
4 papers found
Refreshing results…
A DNA methylation-based liquid biopsy for triple-negative breast cancer
Development and initial clinical correlation of a DNA methylation‐based blood test for prostate cancer
BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers
Region-specific glucocorticoid receptor promoter methylation has both positive and negative prognostic value in patients with estrogen receptor-positive breast cancer
Missing publications? Search for publications with a matching author name.